SFS
VYGR icon

Sowell Financial Services’s Voyager Therapeutics VYGR Stock Holding History

Sowell Financial Services’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-38
Closed – – 2705
2021
Q1 		$0 Hold
38
– – ﹤0.01% 3311
2020
Q4 		$0 Hold
38
– – ﹤0.01% 2871
2020
Q3 		$0 Hold
38
– – ﹤0.01% 2726
2020
Q2 		$0 Hold
38
– – ﹤0.01% 2683
2020
Q1 		$0 Hold
38
– – ﹤0.01% 2717
2019
Q4 		$1K Hold
38
– – ﹤0.01% 2441
2019
Q3 		$1K Buy
+38
New +$798 ﹤0.01% 2321

Other funds holding VYGR

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Sowell Financial Services's VYGR Position: Q2 2021 in Review

Sowell Financial Services sold out of Voyager Therapeutics (VYGR) in Q2 2021, closing a stake of 38 shares.

Sowell Financial Services first reported a position in VYGR in Q3 2019 and held it in 7 quarters. The position peaked at $1K in Q4 2019. 78 funds tracked by Wall St. Rank hold VYGR as of Q2 2021.

  • Sowell Financial Services reported no remaining Voyager Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 38 Voyager Therapeutics shares in Q2 2021.
  • Sowell Financial Services first reported a position in Voyager Therapeutics in Q3 2019 and held it in 7 quarters.
  • Sowell Financial Services's Voyager Therapeutics position peaked at $1K in Q4 2019.
  • 78 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.